search
CRISPR
Trends
- 1Single CRISPR treatment halves bad cholesterol for a year●One CRISPR treatment cut “bad” cholesterol in half for a full year
A one-time CRISPR gene-editing treatment reduced LDL, the so-called bad cholesterol, by about half, with the effect lasting a full year, according to a study reported by ScienceDaily. The result points to durable cholesterol control from a single infusion rather than daily medication, and is drawing attention as a potential new approach to preventing heart disease.